FindTrial
Sign In

The Clinical Value of Peripheral Blood Circulating Tumor Cells in the Diagnosis and Prognosis of Colorectal Cancer

The Clinical Value of Peripheral Blood Circulating Tumor Cells in the Diagnosis and Prognosis of Colorectal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109026
Enrollment
Unknown
Registered
2025-09-10
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

CRC:NONE
Colorectal adenoma:NONE

Sponsors

Foshan Fosun Chancheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria (for CRC patients): (1) Pathologically diagnosed as colorectal cancer; (2) No other malignant tumors or metastatic lesions; (3) No anti-tumor treatment received; (4) Complete clinicopathological data. Inclusion criteria (for colorectal adenoma patients): (1) Pathologically diagnosed as colorectal adenoma; (2) No malignant tumors or metastatic lesions; (3) No anti-tumor treatment received; (4) Complete clinicopathological data.

Exclusion criteria

Exclusion criteria: 1. Patients with leukemia, lymphoma, abnormally elevated white blood cells, bone marrow transplantation, or those who have received white blood cell-containing preparations within 1 month; 2. Pregnant or lactating women; 3. Patients who have received radiotherapy, chemotherapy, or surgical treatment before specimen collection.

Design outcomes

Primary

MeasureTime frame
Circulating tumor cells in peripheral blood;—

Countries

China

Contacts

Public ContactKang Yang

Foshan Fosun Chancheng Hospital

13168557961@163.com+86 131 6855 7961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026